This HTML5 document contains 189 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n10http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n11https://scigraph.springernature.com/pub.10.1186/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34001177
rdf:type
wikibase:Item
schema:description
videnskabelig artikel (udgivet 2011) vitskapeleg artikkel artículo científico publicado en 2011 artikulong pang-agham wetenschappelijk artikel scienca artikolo مقالهٔ علمی vedecký článok tieteellinen artikkeli articolo scientifico мақолаи илмӣ 2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած επιστημονικό άρθρο 2011年论文 bài báo khoa học vědecký článek 2011年論文 مقالة علمية наукова стаття, опублікована в серпні 2011 tudományos cikk 2011 թվականի օգոստոսին հրատարակված գիտական հոդված bilimsel makale 2011年の論文 2011年论文 научная статья სამეცნიერო სტატია سائنسی مضمون 2011年论文 mokslinis straipsnis artigo científico 2011年論文 2011년 논문 artículu científicu espublizáu en 2011 2011 nî lūn-bûn articol științific artigo científico (publicado na 2011) teaduslik artikkel artikull shkencor мақолаи илмӣ scientific article vetenskaplig artikel 2011年论文 מאמר מדעי article científic wissenschaftlicher Artikel научна статия naučni članak 2011年论文 artigo científico (publicado na 2011) article scientific 2011年論文 2011年論文 научни чланак artykuł naukowy 2011年論文 บทความทางวิทยาศาสตร์ 2011年论文 vitenskapelig artikkel ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ article scientifique (publié 2011) научни чланак
p:P577
wds:Q34001177-93270BE6-1391-471C-A6B9-CA50FDC544EB
wdt:P577
2011-08-23T00:00:00Z
p:P407
wds:Q34001177-0F86598E-92D6-450B-88DE-DC538C4287BB
wdt:P407
wd:Q1860
p:P2888
wds:Q34001177-4522936A-DFFC-4A2E-BEBA-D5F4FEEB2101
wdt:P2888
n11:1471-2407-11-367
p:P2860
wds:Q34001177-FBA0C00C-2D22-4E3E-9B2A-57645E9680B6 wds:Q34001177-FE75AE17-E142-4A9A-BD7A-28EB148E4754 wds:Q34001177-A979993E-C6AC-4C19-891F-B1E1632C295C wds:Q34001177-AD218377-3359-4ECE-BC45-DE5A5062091F wds:Q34001177-B5BDE2E3-3F29-41A0-BB4C-37990FD96503 wds:Q34001177-BBF21090-2531-48B5-A9D7-B62C9B6E231B wds:Q34001177-C0439E09-C42D-43AE-A9C0-EDB2AE292142 wds:Q34001177-E4C157C7-FF41-4DF5-B4A4-C728226613D2 wds:Q34001177-F751A82C-C3DD-4420-9025-BFE82E069CF4 wds:Q34001177-8E2060D8-32B5-4CFB-8EAD-6255E4CD952C wds:Q34001177-8F0E5164-2CB6-4359-B413-7B8071E2A079 wds:Q34001177-9079B0AB-0800-472B-B08C-E9D1FEDF18E1 wds:Q34001177-9B9F1191-816D-4BD6-B6B8-68454331BAF2 wds:Q34001177-A33FE1CD-A54F-4906-AE7F-7946C4EEC7A6 wds:Q34001177-549F0BAB-97B1-4D64-941A-B2ECE390393E wds:Q34001177-651304F2-6F15-4630-9DF6-3BEF7E43B7F7 wds:Q34001177-7106B4EC-0742-4630-B2E8-EBA8C708EA80 wds:Q34001177-744471D5-9EDF-4BCB-B60F-8EFAF73B3AFB wds:Q34001177-11C5A9A8-E7D9-4393-BA4B-C71DEE52B37D wds:Q34001177-1851EC8B-CC84-4F87-BFE6-E46083C4E466 wds:Q34001177-28411F06-4833-434D-AE9A-1E7D36CA26C0 wds:Q34001177-33314EC2-4A22-435D-9511-F0DA215EEFAA
wdt:P2860
wd:Q53232788 wd:Q80345359 wd:Q37502551 wd:Q24569561 wd:Q34207262 wd:Q46817228 wd:Q34371152 wd:Q59901665 wd:Q43528801 wd:Q28248823 wd:Q36912586 wd:Q37192912 wd:Q34581085 wd:Q37706863 wd:Q34583973 wd:Q27863454 wd:Q29622818 wd:Q81899161 wd:Q34590731 wd:Q37674335 wd:Q33389870 wd:Q37287048
p:P2093
wds:Q34001177-5E2BA14A-9AC9-4B3D-843B-6DB5D482F2D8 wds:Q34001177-64BF5A3B-3985-48AB-8013-83BF4AF22F4E wds:Q34001177-8EC5D55A-4CBF-4543-B804-1A6CCDE35359 wds:Q34001177-8CA4CBCA-5A6E-449B-8F61-70DAF5B372F8 wds:Q34001177-7F046229-2236-4F05-895C-9A4A3214A527 wds:Q34001177-84FA4673-3AEF-46F8-A47F-734F50B7EFAE wds:Q34001177-7A85BA57-28B3-4D4C-9E85-3BC1ABA9BFDA wds:Q34001177-9626AADD-13A4-4962-BE0E-FF18EFC9223C wds:Q34001177-8FCEF455-5B6C-4FCB-99A5-3C673A43459F wds:Q34001177-ADCD0531-8118-41B9-BB71-7D46EDC809DE wds:Q34001177-A62E80A9-908B-405B-AC18-86FC331A2044 wds:Q34001177-A50CA67E-085E-4DE9-8935-FB4EAAE87ABA wds:Q34001177-DD17E3DD-3DA0-466C-A378-4512E1AD4FF1
wdt:P2093
Jens Freiberg-Richter Markus Bangerter Axel Hinke Clemens Giessen Philipp Aubele Volker Heinemann Christoph Schulz Nicolas Moosmann Dominik Paul Modest Christian Teschendorf Frank Kullmann Markus Sieber Claudio Denzlinger
rdfs:label
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial
skos:prefLabel
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial
schema:name
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial
p:P50
wds:Q34001177-BC120BE9-6C7F-4F50-9B40-EFE2C5A08072 wds:Q34001177-6BE84A1B-516D-496A-AB71-0B15170A93DB wds:Q34001177-562C2F3A-E1EA-4F34-85EA-5254CC937D93 wds:Q34001177-8D2F769A-1F72-4FBD-9C2E-84D7DC79652F
wdt:P50
wd:Q47158566 wd:Q47158556 wd:Q57156755 wd:Q65559556
p:P1476
wds:Q34001177-7ED3D935-91C4-4E9C-8191-0193AA5D9E51
wdt:P1476
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial
p:P304
wds:Q34001177-54FC3974-9FBF-4CA5-AFBE-1FD6EC40737F
wdt:P304
367
p:P31
wds:Q34001177-BBF3B254-3D4E-47C2-B28E-EFD023129919
wdt:P31
wd:Q13442814
p:P921
wds:Q34001177-74B35B1F-4454-4E92-BD37-97CB0F7DE259 wds:Q34001177-56A0C0F9-0904-47A2-8BBE-B82EEA1674FF wds:Q34001177-34984017-FB8C-4398-8374-78DA983FAB1F wds:Q34001177-5191F632-D2EC-4A00-9860-994189FDCEAF wds:Q34001177-FA33A488-ACB2-499B-84E0-E6BAB03A103B wds:Q34001177-A547F9D5-B2D3-4B08-A0D5-48C7061A9A11
wdt:P921
wd:Q413299 wd:Q412197 wd:Q108566365 wd:Q188874 wd:Q420207 wd:Q42824827
p:P698
wds:Q34001177-00D5B906-B058-498F-8244-0CB2FA604A8C
wdtn:P698
n12:21861888
wdt:P698
21861888
p:P1433
wds:Q34001177-75A1BF5E-540A-4607-B5BD-7ADF3D22EF32
wdt:P1433
wd:Q326300
p:P478
wds:Q34001177-D92CE6B6-DA4A-428B-8CA4-D08D87C2145A
wdt:P478
11
p:P356
wds:Q34001177-0363D62A-59A5-4CCA-A528-AE88BA7A1291
wdtn:P356
n10:1471-2407-11-367
wdt:P356
10.1186/1471-2407-11-367
p:P5875
wds:Q34001177-A1019D06-9A46-4B26-8596-32656F9A5B37
wdt:P5875
51590521
p:P6179
wds:Q34001177-4CC487C7-CF27-490A-B464-1DD1F8FFC980
wdt:P6179
1035423861
p:P932
wds:Q34001177-1BBE24CE-D343-4C2A-98A2-6D85E0C12CB9
wdt:P932
3173448